Yes - I too saw that very chunky top-line bid at 78.5c
Additional contracts are imminent & the quarterly isn't too far away now either
Looks to me that the buying is getting more & more aggressive as there are so few holders looking to let any go - you can see that by the very thin sell side & the light volumes going through ... i.e. if you want a decent position, you'll need to chomp away
The 4C (Quarterly) is going to be very interesting by way of the activities statement part - Very keep to read the commentary on the traction being achieved via the rollout
Not expecting anything by way of revenues given they only just began the rollout program & the latest update explained the time-line for cash flow receipts from signing the clinics & then treating the patients
Presently, it's all about scale scale scale for OVN
IMO They've got a cracker of a product which is FDA approved & are looking to challenge big-brother Resmed in their key markets of USA, Canada & Australia
OVN Price at posting:
78.5¢ Sentiment: Buy Disclosure: Held
